Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.260
+0.050 (4.13%)
At close: Apr 28, 2026, 4:00 PM EDT
1.246
-0.014 (-1.11%)
Pre-market: Apr 29, 2026, 8:44 AM EDT
Dermata Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5 | 6 | 3 | 2 | 5 | 14 | |
| Market Cap Growth | 15.50% | 124.01% | 27.62% | -56.38% | -65.85% | - | |
| Enterprise Value | -2 | 2 | -3 | -4 | -3 | 2 | |
| Last Close Price | 1.26 | 2.32 | 13.50 | 91.50 | 981.60 | 4176.00 | |
| PB Ratio | 0.54 | 0.99 | 1.77 | 0.34 | 0.82 | 1.43 | |
| P/TBV Ratio | 0.81 | 0.99 | 1.77 | 0.34 | 0.82 | 1.43 | |
| Net Debt / Equity Ratio | -1.21 | -1.21 | -2.02 | -1.17 | -1.04 | -1.07 | |
| Net Debt / EBITDA Ratio | - | - | - | - | - | 1.37 | |
| Quick Ratio | 4.59 | 4.59 | 1.60 | 4.58 | 6.78 | 7.12 | |
| Current Ratio | 4.79 | 4.79 | 1.79 | 4.91 | 7.53 | 7.66 | |
| Return on Equity (ROE) | -194.20% | -194.20% | -310.44% | -125.96% | -119.18% | -228.09% | |
| Return on Assets (ROA) | -85.25% | -85.25% | -135.86% | -67.36% | -65.13% | -80.31% | |
| Return on Capital Employed (ROCE) | -124.90% | -124.90% | -801.60% | -126.50% | -160.70% | -77.70% | |
| Earnings Yield | -149.15% | -122.48% | -446.00% | -361.07% | -194.19% | -54.53% | |
| Buyback Yield / Dilution | -505.46% | -505.46% | -684.76% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.